Skip to main content
Research and innovation

How the EU supports research and innovation on cancer

Cancer now accounts for a quarter of all deaths and is the number one cause of death for people aged 45-64 in an increasing number of EU countries. Cancer is likely to remain one of the biggest killers in the 21st century.

Global research efforts to fight cancer have been ongoing since the 1970's to turn this disease into a chronic, instead of a fatal one.

Research in this area continues under Horizon Europe.

The past years have witnessed a dramatic progress in understanding the molecular mechanisms at work in the transformation of a normal cell into a cancer cell. Yet, our knowledge is still far from complete and much remains to be discovered.

Intensive collaboration between scientific, medical, technological and industrial communities is indispensable.

Research and innovation on cancer has been and remains a high priority for the EU.

Cancer has been designated as a mission area in the preparation of Horizon Europe, the next research and innovation funding programme.

Related documents

EU Research and Innovation in the fight against cancer (factsheet)

Fighting cancer through research (Infographic)

Melanoma skin cancer (Factsheet)

Funding opportunities

Funding for health under the research and innovation framework programme, Horizon Europe.

Mission cancer aims to improve the lives of more than 3 million people by 2030.

Projects and results

Collaboration and jobs

Look for project partners and view profiles of all organisations that have received funding via the funding and tender opportunities portal.

EU-funded project - a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research.

Scientific publications, tools and databases

Interactive reporting platform, composed of a set of sheets that allows series of views to discover and filter Horizon Europe data.

Single point of access to open data produced by the EU institutions. All data free to use for commercial and non-commercial purposes.

You can access all scientific publications from EU funding via OpenAIRE.